Mein Warenkorb

4-1BB Ligand

4-1BB Ligand Molekülinformation

Englischer NameTumor necrosis factor ligand superfamily member 9Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-Alias4-1BB ligand,4-1BBL
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameTumor necrosis factor ligand superfamily member 9
Target-Alias4-1BB ligand,4-1BBL
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

4-1BB Ligand Produktliste

  • Attribut

    Protein (9)Cell (1)Cell Grade Beads (1)Kits (1)

  • Produktbibliothek

    Online (12)

  • Spezies

    Mouse (1)Human (9)Rat (1)Cynomolgus (1)

  • Etikett

    Fc Tag (5)Fc Tag & Avi Tag (1)His Tag & Flag Tag (2)- (3)Avi Tag & Fc Tag (1)

  • Marker

    Unconjugated (7)Biotin-labeled (2)- (3)

4-1BB Ligand Molekülhintergrund

Tumor necrosis factor ligand superfamily member 9 (4-1BBL) is also known as 4-1BB ligand, CD137L or TNFSF9, which is a cytokine that binds to TNFRSF9. 4-1BBL is the high affinity ligand of 4-1BB. 4-1BBL induces the proliferation of activated peripheral blood T-cells. Also, 4-1BBL may have a role in activation-induced cell death (AICD). Furthermore, 4-1BBL may play a role in cognate interactions between T-cells and B-cells/macrophages. As for diseases, 4-1BBL is involved in cancers, infectious diseases and autoimmune diseases.

4-1BB Ligand Molekülalias

4-1BB Ligand,TNFSF9,CD137L

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
RTX-224RTX-224Phase 2 ClinicalRubius Therapeutics IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Details
RP-3RP-3Phase 2 ClinicalReplimune IncBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details

Produktrezensionen

  • P***l2025-05-30
    3Menschen mögen
    Hi, I work for a start-up company, Nkure Therapeutics, in Bangalore. We have used GMP-4-1BBL from AcroBio and it worked well in our hands for a therapeutic dose. We culture primary cells as such NK cells to provide a cell therapy against cancer. We are happy with the service and the product quality as well. We compared the data of NK cell expansion with Croyez 4-1-BBL and AcroBio 4-1-BBL and realized there is no difference in the potency, however there is a huge difference in the price. AcroBio provides smaller pack size with a good price range as well.
  • a***n2025-02-06
    3Menschen mögen
    Your FACS antibodies of great. worked greatly to study immune cell and activation markers study with extradentary available conjugates for Flow cytometry
  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns